The Wolverine Stack: What BPC-157 and TB-500 Are Actually Doing Inside Your Body
The Peptide Pulse — The Wolverine Stack: What BPC-157 and TB-500 Are Actually Doing Inside Your Body
Channel: The Peptide Pulse · Our label: Dedicated peptide podcast · Source: youtube.com/watch?v=AVHUrawGGIM
What this video covers
[music] [music] Welcome back to the peptide pulse. I am the peptide researcher and I’m super excited to bring this episode to you today. We’re going to be talking about something that well everybody talks about. It’s probably the most widely talked about peptide stack on the market, the Wolverine peptide stack.
Summary drawn from this video’s own transcript (banked in our research library, pulled 2026-11-07). Claims below are the speaker’s — attributed, not endorsed. This site publishes no dosing, protocol, or sourcing information.
Key points, in the speaker’s own framing
- It’s probably the most widely talked about peptide stack on the market, the Wolverine peptide stack.
- Adam Bunder, the peptide researcher, and I’m here to decode the latest breakthroughs, demystify therapeutic biotools, and bring real life stories that, well, redefine health.
- Okay, so at the simplest level, the Wolverine stack is really just the nickname for combining two peptides BPC-157 and TB500.
- So in in preclinical research BPC57 has been studied for pathways related to tissue response, gut barrier models, uh blood vessel signaling and angioenesis, tendon and ligament models, inflammatory signaling and wound models.
- That matters because most of the BPC157 evidence is mechanistic and animal-based, not large-scale human trials.
- We have pre-clinical studies, mechanistic studies, animal models, wound healing models, tendon and tissue models, gut barrier models, angioenesis models, that’s new blood vessel growth.
Read next
Educational information only — not medical advice. Peptides discussed on this page include substances that are not FDA-approved.